B. Murray

A Tool for Investigating Asthma and COPD Exacerbations: A Newly Manufactured and Well Characterised GMP Wild-Type Human Rhinovirus for Use in the Human Viral Challenge Model

Daniel J. Fullen, Rob Lambkin-Williams, A. Mann, 2016, PloS one.

Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study

Rob Lambkin-Williams, A. Gilbert, H. Schuitemaker, 2021, The Journal of infectious diseases.

Safety and Antiviral Effects of Nebulized PC786 in a Respiratory Syncytial Virus Challenge Study

Kazuhiro Ito, P. Strong, J. Devincenzo, 2020, The Journal of infectious diseases.

LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study

E. Coakley, Kai Lin, K. Larson, 2019, Open Forum Infectious Diseases.

EDP-938, a Respiratory Syncytial Virus Inhibitor, in a Human Virus Challenge.

N. Noulin, J. Mori, N. Adda, 2022, The New England journal of medicine.